Clinical
‘Might be a way to make this mess work’: vapes
We’ve received a deluge of comments from our readers on the controversial S3 vape legislation. Here’s a selection of reader comments From 1 July, pharmacies are the only retailers authorised …
‘No quick fix’ for pelvic pain
Pharmacists are “often the first port of call” for women with pelvic pain. Knowing the relevant medicines, red flags and when to refer are top of the list on how …
Smoking cessation meds in pregnancy need more evidence: study
Women need more support to quit smoking during pregnancy but there is a lack of evidence around medicines safety, say researchers A UNSW Sydney-led study of 1.7 million pregnancies in …
Credentials for consultants launch
The PSA has launched its full suite of credentials, including pathways for both experienced consultant pharmacists and those looking to expand their practice The Medication Management Review (MMR) credential and …
A better choice
Pharmacist “champions” can assist prescribers to make more informed choices on empirical prescribing of antibiotics, study finds More education is needed for prescribers to use antibiograms to improve their antibiotic …
‘Pharmacists will be challenged to justify a therapeutic need’
A hospital pharmacist with years of experience in the respiratory specialty has seen a “significant” increase in vaping-related illness – and says the new vaping legislation puts members of the …
Long-term opioids higher after ED, trauma admissions
Codeine combinations most dispensed after hospital discharge, with some groups revealing higher rates of long-term opioid use, study finds Long-term use of opioids following hospital admission or emergency department (ED) …
Deprescribing missing from guidelines
New research has found many clinical practice guidelines contain limited guidance on deprescribing… could pharmacists be the missing link? Deprescribing recommendations are becoming more common but are still missing from …
‘Any symptoms that cause distress should be taken seriously’
Antidepressant withdrawal symptoms affect around one in six people, a large study estimates, after taking into account the “nocebo” effect One in six people who stop taking antidepressants experience discontinuation …
June MIMS update
A look at some of the recent changes to the medicines landscape, with new products and indications New Products Avacopan (Tavneos) is a selective antagonist of the human complement 5a …
Emergency pharmacists speed up pain relief
Pharmacists included on trauma response teams significantly improve speed and delivery of pain relievers to trauma patients, Melbourne trial finds The Pharmacists in Trauma (PHIT) Trial, conducted by Alfred Health …
Withdrawal a ‘very rare’ reaction, argues college
Topical corticosteroids are safe and effective, urge leading dermatology and eczema organisations in response to recent media reports about topical steroid withdrawal ABC News Breakfast reported on topical steroid withdrawal …